Company Filing History:
Years Active: 2018
Title: Marie Momot: Innovator in Immunotherapeutic Treatments
Introduction
Marie Momot is a distinguished inventor based in Toulouse, France. She has made significant contributions to the field of immunotherapy, particularly through her innovative research and development of polypeptide-based treatments. Her work aims to enhance immune responses in mammalian hosts, addressing various pathological conditions.
Latest Patents
Marie Momot holds a patent for her invention titled "CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses." This invention focuses on utilizing CyaA-carried polypeptides to elicit T cell immune responses against specific epitopes. The therapeutic applications of her invention are aimed at treating diagnosed pathological conditions, while the prophylactic aspects target the prevention of other conditions by inducing T cell memory immune responses.
Career Highlights
Marie is currently associated with Genticel, where she continues to advance her research in immunotherapy. Her dedication to innovation has led to the development of groundbreaking treatments that have the potential to improve patient outcomes significantly. With her expertise, she is paving the way for new therapeutic strategies in the medical field.
Collaborations
Marie collaborates with notable colleagues, including Michael Esquerré and Anne Goubier. These partnerships enhance her research efforts and contribute to the advancement of immunotherapeutic solutions.
Conclusion
Marie Momot is a pioneering inventor whose work in immunotherapy is making a profound impact on the treatment of various diseases. Her innovative approach and dedication to research exemplify the spirit of invention in the medical field.